Professional Education
Prevention of Medical Errors 2024 to 2026 (National)
Few medical errors are attributed to faulty medical judgment. More commonly, they are attributed to system failures inherent in healthcare delivery. By drawing on our professional liability closed claims data, we have identified common performance and diagnostic errors. We analyzed loss prevention measures in tandem with the elements necessary to conduct a credible and thorough root cause analysis to reduce system failures, respond to sentinel events, prevent medical errors, and improve patient safety. The purpose of this program is to provide clinicians with the most current information regarding the prevention of common performance and diagnostic errors.
Search
December 28, 2023, Managed Healthcare Executive
2024 Prediction from Laura Kline, MBA, CPCU
Laura Kline, MBA, CPCU, Senior Vice President, Business Development, The Doctors Company and TDC Group, offers her prediction on how advanced practice clinicians (APCs) will be critical to access care in 2024.
2023 Great Place to Work Certification
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, is pleased to announce the company is Certified™ as a Great Place to Work® in 2023. This is the second time the company has received this prestigious designation.
Recording Office Visits and Procedures
Proactively addressing the use of electronic recordings can help practitioners avoid misunderstandings, reputational damage, and potential liability.
Aug 27, 2024
Patient Safety Impact Story: Mislabeled Diagnostic Specimens Put Lab Team at Risk
We share an example of how our experts partnered with a member practice to mitigate risk.
From
The Doctor’s Advocate
May 01, 2024, ED Management
Communication Is Major Contributing Factor to ED Malpractice Claims
Jacqueline Ross, RN, PhD, Coding Director in the Department of Patient Safety and Risk Management at The Doctors Company, discusses emergency department (ED) malpractice claims that contain allegations that delayed diagnoses led to poor outcomes or death.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Video Aug 29, 2025
Challenges to Scaling Adoption of Hospital at Home
Michael J. Maniaci, MD, Director of Enterprise Virtual Care, Mayo Clinic, presents at the 2025 TDC Group Executive Advisory Board Meeting about the top challenges when implementing hospital at home programs.
August 01, 2025, Healthcare Risk Management
DOJ Targeting Healthcare for False Claims Act Enforcement
Federal regulators and law enforcement are looking at healthcare organizations for False Claims Act (FCA) violations. Richard F. Cahill, JD, Vice President and Associate General Counsel at The Doctors Company, provides recommendations for healthcare providers to review their compliance programs to avoid FCA enforcement actions.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
